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Abstract 17 
Escherichia coli O157 is a zoonotic bacterium that can cause haemorrhagic diarrhoea in 18 
humans and is of worldwide public health concern. Cattle are considered to be the main 19 
reservoir for human infection. Fasciola hepatica is a globally important parasite of ruminant 20 
2 
 
livestock that is known to modulate its host’s immune response and affect susceptibility to 21 
bacterial pathogens such as Salmonella Dublin.  Shedding of E. coli O157 is triggered by 22 
unknown events, but the immune system is thought to play a part.  We investigated the 23 
hypothesis that shedding of E. coli O157 is associated with F. hepatica infection in cattle. 24 
Three hundred and thirty four cattle destined for the food chain, from 14 British farms, 25 
were tested between January and October 2015.  E. coli O157 was detected by 26 
immunomagnetic separation and bacterial load enumerated.  F. hepatica infection status 27 
was assessed by copro-antigen ELISA.  A significant association (p = 0.01) was found 28 
between the log percent positivity (PP) of the F. hepatica copro-antigen ELISA and E. coli 29 
O157 shedding when the fixed effects of day of sampling and the age of the youngest 30 
animal in the group, plus the random effect of farm were adjusted for. The results should 31 
be interpreted cautiously due to the lower than predicted level of fluke infection in the 32 
animals sampled. Nevertheless these results indicate that control of F. hepatica infection 33 
may have an impact on the shedding of E. coli O157 in cattle destined for the human food 34 
chain. 35 
Keywords: Escherichia coli O157, Fasciola hepatica, cattle, co-infection 36 
1 Introduction 37 
Fasciola hepatica, or the common liver fluke, is a parasite of ruminant livestock, occurring 38 
worldwide. Various studies have shown that F. hepatica can affect host immunity to other 39 
pathogens (Moreau and Chauvin, 2010), by making the host more susceptible to infection 40 
(Aitken et al., 1979, 1981; Brady et al., 1999); changing the pathogenesis of disease (Garza-41 
Cuartero et al., 2016); and interfering with diagnostic tests (DEFRA, 2005; Flynn et al., 42 
2007). This happens because infection with F. hepatica induces a mixed T helper type-2 43 
(Th2) and T-regulatory response, with increased production of IL4, IL5, IL10, IL13 and TGFβ, 44 
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whilst T helper type-1 (Th1) responses are down regulated (Flynn et al., 2010; Graham-45 
Brown, 2016).  46 
Escherichia coli O157 is a zoonotic bacterium that occurs worldwide and can cause 47 
haemorrhagic diarrhoea in humans as a result of systemic Shiga toxin (Stx) activity. Cattle 48 
are considered the main source of human infection, either through direct contact or 49 
through contaminated food (Locking et al., 2001; Strachan et al., 2006; Gyles, 2007). An 50 
estimated 20-40% of British cattle herds are reported to shed E. coli O157 (Paiba et al., 51 
2003; Ellis-Iversen et al., 2007; Gunn et al., 2007; Pearce et al., 2009).  The annual reported 52 
incidence of human E. coli O157 is 1.8 culture positive cases per 100,000 population in 53 
England and Wales, and 4.5 cases per 100,000 in Scotland (Health Protection Network, 54 
2013; Public Health England, 2013). In a proportion of cases, mainly in young children, 55 
haemolytic uraemic syndrome may occur, and is potentially fatal (Chase-Topping et al., 56 
2008).  57 
Escherichia coli O157 infections in cattle are usually asymptomatic as cattle lack vascular 58 
receptors for Stx (Pruimboom-Brees et al., 2000), but both cellular and humoral immune 59 
responses are induced and are required for immunity to E. coli O157  (Corbishley et al., 60 
2014, 2016). Furthermore, cellular responses to E. coli O157 are associated with Th1 61 
responses (Corbishley et al., 2014). The relationship between the shedding of E. coli and 62 
immunity is not fully understood, but shedding has been associated with stressful events 63 
that could affect the immune response (Ellis-Iversen et al., 2007; Munns et al., 2015).  64 
Recent estimates using bulk milk antibody detection ELISAs based on fluke excretory-65 
secretory antigens show 50 - 80% of UK dairy herds have been exposed to fluke (McCann et 66 
al., 2010; Howell et al., 2015). Although the current status for the beef sector is unknown, 67 
figures released by the Food Standards Agency report that 16.5% of cattle livers were 68 
condemned due to liver fluke during 2015 (Ford and Hadley, 2015). Since liver fluke 69 
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infection down-regulates Th1 responses, which are associated with clearance of the 70 
bacteria from the bovine gut (Corbishley et al., 2014), we hypothesized that fluke infection 71 
could affect the propensity of cattle to shed E. coli O157. If so, the presence of co-infected 72 
cattle could increase the risk of zoonotic E. coli infections. 73 
2 Methods 74 
This study was designed to utilise samples collected for an existing larger study on E. coli 75 
O157 in cattle intended for human consumption, funded by Food Standards Scotland (FSS) 76 
and the Food Standards Agency (FSA; Project FS101055); referred to below as the FSS/FSA 77 
study. For the FSS/FSA study, sample size calculations showed that a minimum of 110 78 
Scottish farms and 160 farms from England and Wales were required to estimate a 79 
prevalence of E. coli O157 of 20% and 35% respectively within a tolerance of 0.168 with 80 
95% confidence (Henry et al., 2017). 81 
A sample size calculation to determine the number of cattle that were required to 82 
investigate the association between F. hepatica infection and E. coli O157 shedding was 83 
performed by Hickey et al. (2015) using simulated datasets. The estimated prevalence of E. 84 
coli O157 was set at 4% of cattle and 20% of farms (Pearce et al., 2009) whilst the estimated 85 
prevalence of F. hepatica was set at 20% of cattle and 80% of farms (Salimi-Bejestani et al., 86 
2005b; McCann et al., 2010).  100% sensitivity and specificity of both tests were assumed.  87 
The result of using these parameters was that the inclusion of 1645 individual samples, 88 
from 50 randomly selected farms, would give the study a power of 87% to detect a two-fold 89 
increase in the odds that an animal would shed E. coli O157 if it was also infected with 90 
F. hepatica, compared to cattle not infected with fluke. 91 
2.1 Sample and data collection 92 
Two hundred and seventy farms were sampled in the FSS/FSA study (Henry et al., 2017). 93 
These included a variety of types of enterprise and breeds of cattle. Of these, 110 were 94 
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Scottish farms, randomly selected from all Scottish farms that had participated in both of 95 
two earlier studies. The inclusion criterion was that there was at least one male aged one 96 
year or over, or female over two without calves on the farm, as these farms were most 97 
likely to contain animals that would end up in the food chain. In addition, 160 farms for 98 
England and Wales were recruited from a randomly selected subset with either a male of 99 
any breed aged over 1 year, or a female of a non-dairy breed aged over 1 year. Farmers 100 
were initially notified by letter and given the choice to opt out, and were then contacted by 101 
phone in a randomised order to enrol them in the study.  102 
Farms were visited once between September 2014 and November 2015. Individual fresh 103 
faecal pat samples were taken from the floor or ground, for the group of cattle from each 104 
farm that contained the animals closest to going off the farm for slaughter. The number of 105 
samples collected from each group was determined by a protocol assuming that if 8% of 106 
animals were positive, there would be a 0.9 probability of identifying groups containing at 107 
least one positive animal (Chase-Topping et al., 2007). It was assumed that a pat sample is 108 
equivalent to an animal level unit for analysis. These samples were then sent to the 109 
Epidemiology Research Unit (ERU) microbiological facilities at Scotland’s Rural College 110 
(SRUC), Inverness, within 48 hours of collection, and tested for E. coli O157. The 111 
recruitment and visits were done by members of SRUC project team in Scotland, and the 112 
ADAS project team in England and Wales.  113 
Farms for which samples were submitted to SRUC’s ERU laboratory on or after 5th January 114 
2015, and which consented to further use of their samples and data for research purposes, 115 
were included in the study. Delays due to funding and contractual issues meant that 116 
samples received prior to this date were not retained.  117 
Information on animal characteristics and farm management was collected from the 118 
livestock keeper or farm manager on each farm, via a questionnaire administered by the 119 
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survey staff. The information was collected in an electronic format and was a shortened 120 
version of a questionnaire used in a previous study (Chase-Topping et al., 2007). The 121 
questionnaire was piloted with several farmers before use. The finalised questionnaire was 122 
approved by the FSS Survey Control team (Henry et al., 2017). The questionnaire was 123 
conducted in Welsh for Welsh-speaking respondents.  124 
The information obtained was at the farm level, for example the age of animals was given 125 
as a range for the group, and all animals in a group were treated as having been managed 126 
the same in terms of housing, feeding and treatments given. The information relevant for 127 
the current study was identified and extracted. As the aim was to develop a model to 128 
determine the presence of an association between fluke and E. coli O157, rather than a 129 
predictive model, only management information relevant to fluke was taken for use in the 130 
model, to control for possible confounders which may be linked to both fluke and E. coli 131 
O157.  A summary of these is shown in Table 1. 132 
2.2 E. coli testing 133 
One gram of faeces was added to 20 ml of buffered peptone water (BPW, Thermo 134 
Scientific, UK).  The BPW was incubated for six hours at 37°C (±1°) then subjected to 135 
immunomagnetic separation (IMS). Briefly, a 1 ml aliquot from each 20 ml BPW sample was 136 
added to 20 µl paramagnetic beads coated with polyclonal antibody for E. coli O157 137 
lipopolysaccharide (Lab M Ltd., UK).  The aliquots were mixed on a rotary mixer for 30 138 
minutes before being washed three times in PBS with 0.05% Tween 20 (PBST, Sigma-Aldrich 139 
Co. Ltd.).  After the third wash, the beads were re-suspended in 100 µl PBST and cultured 140 
onto MacConkey agar containing sorbitol, cefixime (0.05 mg/l) and tellurite (2.5 mg/l) (CT-141 
SMac, Thermo Scientific, UK)(Jenkins et al., 2003).   142 
Following overnight incubation at 37°C (±1°) plates were examined for non-sorbitol-143 
fermenting colonies and any suspect colonies were subcultured onto Chromocult coliform 144 
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agar (Merck KGaA., Germany).  After a further overnight incubation at 37°C (±1°) any 145 
resulting red colonies were tested with anti-E. coli O157 latex (Thermo Scientific, UK) for 146 
agglutination.  Colonies that agglutinated were identified as presumptively positive and 147 
enumerated by limiting dilution.   148 
Polymerase Chain Reaction (PCR) was used to confirm the serogroup of the isolates as 149 
E. coli O157 (ISO/TS, 2012). For all positive samples, the number of E. coli O157 were 150 
enumerated by culturing 10-fold dilutions of faeces in minimum recovery diluent, starting 151 
from 1:10, on duplicate CT-SMac  plates. Typical colonies were counted after overnight 152 
incubation at 37°C (±1°) and counts expressed as colony forming units (cfu) per gram of 153 
faeces. 154 
IMS is considered to be a highly sensitive and specific method of identifying E. coli O157, 155 
and has a lower limit of detection of 50 cfu/g (Aydin et al., 2014; Wright et al., 1994). Lower 156 
cfu counts can be detected with decreased sensitivity.  IMS has a specificity of 99% (Ekong 157 
et al., 2017), and all positive isolates were confirmed as such by the Scottish E. coli 158 
Reference Laboratory. For the positive/negative analysis, an E. coli O157 positive cow was 159 
defined as one that tested positive by IMS. The limit of accurate enumeration was 100 cfu/g 160 
of faeces (Pearce et al., 2004), and samples from which too few E. coli were cultured to be 161 
enumerated were assigned a cfu/g of 10.  162 
2.3 F. hepatica testing 163 
Extraneous faecal material (2g), from each faecal sample was weighed into polypropylene 164 
tubes and frozen (-20°C). When the E. coli O157 status of the farms was known (as defined 165 
in Henry et al., 2017), all the samples from eligible E. coli O157 positive farms were  166 
transported to Moredun Research Institute (MRI) in batches. Here they were tested using a 167 
copro-antigen ELISA according to the manufacturer’s instructions (Bio-X Diagnostics, 168 
Jemelle, Belgium).  MRI staff members were blinded to the E. coli O157 status of the 169 
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individual samples. Freezing the samples prior to performing the copro-antigen ELISA is 170 
reported to make no difference to the sensitivity or specificity of the test (Brockwell et al., 171 
2013; Flanagan et al., 2011), and this was also confirmed before this study commenced 172 
(Personal communication, Dr Philip Skuce).  173 
The result was determined by calculating the percentage positivity (PP) of each sample 174 
relative to the optical density (OD) of the positive control, after subtracting the OD of the 175 
negative control (provided in the kit). The positive/negative cut off was determined by the 176 
quality control insert supplied with the kit, and was either 7 or 8 for all the kits used for this 177 
study. This test has a reported sensitivity of 0.77 and a specificity of 0.99 (Mazeri et al., 178 
2016). 179 
2.4 Statistical analysis 180 
The epidemiological unit of interest was the individual animal. For each animal for which a 181 
sample was tested, the following results were obtained: E. coli O157 positive/negative, E. 182 
coli O157 cfu/g, F. hepatica positive/negative derived by applying the cut off to the copro-183 
antigen ELISA results, and F. hepatica PP result (on a continuous scale). Farms without a 184 
single fluke positive animal were excluded from further analysis, to ensure that cattle at 185 
least had a possibility to be infected by fluke, which would not necessarily be the case if 186 
there was no fluke on the farm.  R (R Core Team, 2011) was used, with the lme4 (Bates et 187 
al., 2015) and ggplot2 (Wickham, 2009) packages.  Due to confidentiality agreements 188 
relating to FSS/FSA project FS101055 which funded the faecal sample collection, figures or 189 
data relating to groups of fewer than five farms cannot be shown. 190 
2.5 Multilevel model  191 
Correlations between the numerical explanatory variables were checked to ensure highly 192 
correlated variables were not entered simultaneously into the model. All models were 193 
fitted using maximum likelihood. Linear and logistic regression models were built with log10 194 
E. coli cfu/g and a positive E. coli result respectively as the outcome variable. Either log 195 
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fluke ELISA PP or a positive fluke result was used as the only level 1 explanatory variable, 196 
and all other animal and farm management information were level 2 variables. One and 2 197 
respectively were added to the E. coli O157 count and fluke ELISA PP results before logging 198 
to deal with zero and negative values. 199 
The starting point was a variable intercept model including a positive fluke result as a level 200 
1 explanatory variable and farm as a level 2 random effect. Management variables which 201 
met the inclusion criteria were then added one at a time. A seasonal pattern was expected 202 
for E. coli (Ferens and Hovde, 2011), so day was modelled as a sinusoidal function to allow 203 
for this.  The same process was repeated with fluke PP as the explanatory variable. The 204 
process was then repeated again with log10 E. coli cfu/g as a continuous outcome variable. 205 
Variable slopes were also tested. The Akaike information criterion (AIC) was used to 206 
compare models, with a lower AIC considered better than a higher one.  207 
3 Results 208 
Between 13th January and 19th October 2015, of 39 farms sampled with one or more cattle 209 
testing positive for E. coli O157, two declined to take part in further research and samples 210 
from two farms were delayed in transit and were therefore not suitable for fluke testing. 211 
There was insufficient sample for testing from a further five cows. Therefore, samples from 212 
810 cattle from 35 herds were tested using the F. hepatica copro-antigen test.  Of these, 14 213 
farms had at least one cow testing positive for F. hepatica. Between 7 and 40 cattle were 214 
sampled from each of these farms (median = 22, total = 334) and are included in the 215 
following analysis.  216 
3.1 Descriptive statistics 217 
The characteristics of the farms are shown in Table 1. The data were examined to find out 218 
whether groups of cattle were housed or grazing, how long they had been housed or 219 
grazing for, and whether they had received a worming or flukicide treatment within the 220 
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past 3 months. However, even in groups for which flukicide use was recorded, fluke copro-221 
antigen ELISA positive cattle were still present, and similarly some groups of cattle which 222 
had been housed for several months still had significant numbers of fluke positive animals. 223 
Therefore treatment history was not used to exclude farms and all animals that came from 224 
groups with at least one fluke case were included, on the basis that they would all have had 225 
the chance to become fluke infected.  226 
3.1.1 Animal level  227 
Overall, 50.9% of cattle tested positive for E. coli O157 and 13.2% tested positive for F. 228 
hepatica.  The distributions are shown in figure 1. 229 
3.1.2 Farm level 230 
Within farms, between 4 and 100% of cattle tested positive for E. coli (mean = 43.5%, 231 
median = 43.1%) whilst for F. hepatica the range was 2.1 to 100% (mean = 14.7%, median = 232 
6.5%). The distribution of log E. coli O157 cfu/g varied between farms, but in general it was 233 
right skewed in ten farms whilst four farms showed a more symmetrical platykurtic 234 
distribution. For fluke PP, all except one farm had a right skewed distribution.  235 
The farms were spread throughout Great Britain with six from Scotland, four from England 236 
and four from Wales. North Wales, South Wales, the Welsh borders, Northern England and 237 
a variety of Scottish locations were represented.  238 
3.2 Associations between fluke and E. coli O157 239 
Inspection of scatterplots revealed no visible association between the fluke PP and log E. 240 
coli O157 cfu/g, either at individual or farm level (data not shown). More detailed 241 
inspection of three farms with more than 10% of cattle testing positive for fluke revealed 242 
no consistent pattern with regard to which individuals were positive for which pathogen. In 243 
one farm all of the fluke positive animals were also E. coli positive, in a second farm all of 244 
the fluke positives were E. coli negative, and in a third farm all animals had fluke and the PP 245 
values were evenly spread between the E. coli positive and negative animals.  246 
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3.3 Multi-level models  247 
The plotting of management variables against log10 E. coli O157 cfu/g did not reveal any 248 
non- linear relationships. No correlations of r >0.7 were seen between any of the 249 
explanatory variables, except between numbers of animals of different ages/types.  250 
Four different combinations of output and input variables were tested, to include all 251 
combinations of the F. hepatica and E. coli data. The inclusion of random effects improved 252 
the model fit in every case, indicating that there were important differences between 253 
farms.  The explanatory management variables shown in Table 1 were each added to the 254 
model as level 2 variables, but it was not possible to add more than two variables at once 255 
because of the relatively small number of fluke cases, which led to non-convergence of the 256 
model due to perfect partitioning.  257 
The best models for each combination of E. coli O157 positive and log10 E. coli O157 cfu/g, 258 
and log fluke PP and fluke positive are shown (Table 2). The fluke result did not explain any 259 
additional variation in three out of four models, however, log fluke PP was significant when 260 
modelled against positive E. coli O157 result. Day of sampling and the age of the youngest 261 
animal in the group were included in all of the models at level 2 and were highly significant 262 
in all models (p < 0.0001). The higher the age of the youngest animal in the group, the 263 
lower the odds of infection with E. coli O157. The model fitted better with day of sampling 264 
as a linear variable, and the odds of E. coli O157 was found to decrease throughout the 265 
year, from January until October. The introduction of random slopes worsened the model 266 
fit in each case so this was not pursued.  267 
4 Discussion 268 
This study aimed to use samples available from the FSS/FSA study to investigate whether 269 
shedding of E. coli O157 is associated with F. hepatica infection in cattle (Hickey et al., 270 
2015). E. coli O157 is the serogroup most commonly detected in humans in the UK, Europe 271 
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and the US, and is associated severe clinical outcomes in humans (Anon, 2015; Browning et 272 
al., 2016). The advantage of using the samples from a pre-existing study was efficiency in 273 
terms of reducing resources needed for planning, recruitment of farmers, visiting farms and 274 
testing samples for E. coli O157. However, the biggest disadvantage of using the samples 275 
gathered for the FSS/FSA study was that the sampling method was designed to treat the 276 
group of cattle as the unit of interest; specifically, to identify groups where at least one 277 
animal was shedding E. coli O157 (Gunn et al., 2007; Pearce et al., 2009). E. coli O157 278 
shedding varies widely from day to day (Robinson et al., 2009), and the effective sensitivity 279 
may be as low as 40% for a one-off faecal sample (Echeverry et al., 2005). Whilst this was 280 
not a problem for the FSS/FSA study, where the group was treated as the epidemiological 281 
unit, it may have affected the current study because individuals that were shedding E. coli 282 
O157 may have been missed.  283 
Reaching the required sample size depended on the initial assumptions about prevalence of 284 
the two pathogens being reasonably accurate, particularly as the collection of additional 285 
samples was not possible given the constraints of the study. However, the levels of fluke 286 
infection seen in this study, both at the farm and the animal level, were much lower than 287 
had been assumed for the sample size calculations (Hickey et al., 2015), and F. hepatica 288 
only occurred in 43% of farms compared to the predicted  70-80% (Salimi-Bejestani et al., 289 
2005a; McCann et al., 2010; Hickey et al., 2015). This lower fluke prevalence may be partly 290 
explained by differences between the cattle populations that were the subject of the 291 
FSS/FSA study and previous studies. Data on herd level prevalence of infection is from 292 
lactating dairy cows, whereas the FSS/FSA study sampled mostly beef breed or cross bred 293 
store or finishing animals.  Differences in management exist between these groups that are 294 
likely to affect their risk of fluke infection. For example, treatment for fluke is more difficult 295 
in dairy animals due to the long milk withhold times of flukicides. Also, of the 35 groups of 296 
cattle tested for fluke, only nine were currently grazing, and of those, three had been 297 
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turned out onto pasture within the three weeks prior to sample collection. This could have 298 
been due to the time of year when the samples were collected but also the nature of the 299 
farming units tested. It is possible that some of the groups were permanently housed, 300 
which would put them at low risk of fluke exposure, although this information was not 301 
available from the questionnaire.  302 
The lower than expected prevalence of fluke could also be due to the relatively low 303 
sensitivity of the F. hepatica copro-antigen test, which in naturally infected cattle has been 304 
estimated to be below 50%-60% (Duscher et al., 2011), whereas the bulk milk tank antibody 305 
ELISA used to estimate prevalence in previous studies has a sensitivity of 96% (Salimi-306 
Bejestani et al., 2005a). The difference in sensitivity between the two types of test was not 307 
taken into consideration in the feasibility study (Hickey et al., 2015). The relatively low 308 
sensitivity of the diagnostic tests used for both fluke and E. coli could have led to non-309 
differential misclassification. This is expected to bias the observed effect size towards zero, 310 
although sometimes, by chance, the effect size can be over-estimated (Jurek et al., 2005).  311 
Delays in implementation of this study led to the loss of samples from 17 farms enrolled in 312 
the FSS/FSA study that were sampled between September 2014 and January 2015 and 313 
which had agreed to take part. This contributed to the failure to reach the required sample 314 
size. The missed samples were taken during the season when the within-herd prevalence of 315 
fluke might have been expected to be at its highest (Bloemhoff et al., 2015).  316 
In spite of these challenges, one of our models showed a significant association between F. 317 
hepatica and E. coli O157. This would be consistent with our initial hypothesis that F. 318 
hepatica mediated down-regulation of Th-1 immunity may limit the ability of cattle to clear 319 
E. coli O157 from the intestinal tract: indeed, this would be similar to the previous 320 
observation that F. hepatica infections in cattle result in increased susceptibility to 321 
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Salmonella dublin which is associated with reduced cellular immune responses against the 322 
bacteria (Aitken et al., 1979).   323 
The cut-off of the fluke copro antigen ELISA has been the subject of debate, with some 324 
studies setting their own cut-off to increase sensitivity (Brockwell et al., 2014). A 325 
continuous measure of PP avoids this problem and PP is a biologically meaningful measure 326 
as antigen level is correlated with fluke burden (Kamaludeen, 2016).  327 
The addition of more than two additional explanatory variables was prevented by 328 
insufficient variability within the data. This could partly explain the observed large random 329 
effect of farm, which indicates that there were large differences between farms. Another 330 
interesting question is whether the inter farm differences could be partially explained by 331 
differences between strains of E. coli O157 at the molecular level that might be related to 332 
shedding events and immune status. Indeed it is known that different strains of E. coil O157 333 
induce different types of immune response (Corbishley et al., 2014) and different genetic 334 
traits of E. coli O157, such as phage type (Chase-Topping et al., 2007), presence of stx2a 335 
and stx2c genes and polymorphisms in the tir gene (Arthur et al., 2013), are associated with 336 
either high or low shedding from infected individuals. Although it was important to control 337 
for day of sampling, as season is associated with observed prevalence of both fluke and E. 338 
coli O157 (Bloemhoff et al., 2015; Ferens and Hovde, 2011; Smith et al., 2016; Synge et al., 339 
2003), the strong effect seen here is more likely to be due to all animals from a single farm 340 
being sampled on the same day than a genuine seasonal effect. Therefore caution should 341 
be used when interpreting the direction and size of the seasonal effect. There may also be 342 
other explanatory or confounding variables that are not included in these models. The 343 
result should therefore be interpreted with caution, particularly as the effect size is small 344 
and it is only seen in one of the model combinations. 345 
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The results of our study hint at an association between E. coli O157 shedding and F. 346 
hepatica infection that merits further investigation. Based on our experiences, use of pre-347 
collected samples represents a cost–effective way of obtaining data, however, care needs 348 
to be taken to avoid certain pit falls. In the planning stage of future studies, worst case 349 
scenarios for prevalence should be considered, taking into account diagnostic test accuracy 350 
and differences between populations which may affect apparent prevalence. Even more 351 
importantly, efforts should be concentrated on ensuring that the true infection or shedding 352 
status of each individual can be ascertained, and that the type, number and size of sample 353 
are suitable for this. For E. coli shedding this is likely to include longitudinal sampling to 354 
address the issues of intermittent shedding and uneven distribution of bacteria within the 355 
faeces.  356 
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Table 1. Characteristics of the animals and farms in the fluke and E. coli O157 study 550 
 Farm-level  (n=14) Individual animals 
(n=334) 
Day of sample collection (Day 1=1st Jan 
2014) 
Range = 20-293 
Median = 126 
 
Grazing 
Housed 
3 (21.43 %) 
11 (78.57 %) 
 
Dairy 
Suckler beef 
Finisher 
Other 
2 (14.29 %) 
8 (57.14 %) 
2 (14.29 %) 
2 (14.29 %) 
 
Youngest in group (months) 
 
Oldest in group 
Range = 6-26 
Median = 14.5  
Range = 11-48 
Median = 20 
 
Total number of cattle on farm Range = 41-516 
Median = 117 
 
Total number of cows on farm 
(Females that have had a calf) 
Range = 0-208 
Median = 33 
 
Total number of heifers on farm Range = 0-65 
Median = 6 
 
 
Total number of cattle under 1 year on 
farm 
Range = 0-215 
Median = 30 
 
Total number of ewes on farm Range = 0-700 
Median = 0 
 
Total number of sheep overwintering on 
farm 
Range = 0-433 
Median = 0 
 
Water supply from mains 
Water supply from spring or well 
Water supply from natural source 
10 (71.43 %) 
6 (42.86 %) 
11 (78.57 %) 
 
Median percentage of fluke positive 
cows1 
Range of positive cows 
Fluke positive 
Median PP 
Range PP 
6.55% 
2.13-100% 
 
 
 
44 (13.17%) 
0.82 
-1.07-73.74 
Median percentage of E. coli O157 
positive cows2 
Range of positive cows 
E. coli positive   
Median cfu/g3 
Range cfu/g3 
43.10% 
 
4.00-100% 
 
 
 
170 (50.9%) 
10 
0-1.45 x 105 
1
’Fluke positive’ refers to an animal which tested positive on the copro-antigen ELISA result  551 
2’
E. coli O157 positive’ refers to an animal with a positive IMS E. coli test  552 
3
Samples from which E. coli numbers fell below the limit of enumeration were assigned cfu/g = 10 553 
25 
 
 554 
Figure 1. Distribution of F. hepatica coproantigen PP values and E. coli O157 cfu/g for 555 
animals across all farms.  556 
 557 
Table 2. Summary of the multi-level models. Farm was included as a random intercept. 558 
Day of sampling and age of the youngest animal in the group were controlled for in all 559 
models.  560 
Outcome variable Input variable Co-efficient p value 
E. coli O157 positive F. hepatica  
positive 
0.50 0.34 
E. coli O157 positive Log F. hepatica 
ELISA PP 
0.48 0.010 
log10 E. coli O157 F. hepatica  
positive 
-0.02 0.90 
log10 E. coli O157 Log F. hepatica 
ELISA PP 
0.09 0.26 
E. coli O157 positivity was determined using immune-magnetic separation. log10 E. coli O157 refers 561 
log10 of the E. coli O157 count (cfu/g). F. hepatica positivity was determined using a copro-antigen 562 
ELISA. ELISA PP is the percentage positivity compared to a known positive sample.  563 
 564 
